Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
The SURMOUNT-1 trial published in the New England Journal of Medicine (Jastreboff et al., 2022) showed average weight loss of 20.9 percent of body weight at the highest tirzepatide dose over 72 weeks
Decreases hunger signals, causing a reduction in mental food chatter Promotes metabolic efficiency
Metformin stabilizes blood sugar levels, while semaglutides effects on insulin and appetite support maintaining these levels and aiding weight loss
Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes
Billingsley A et al
US$ 22.84
US$ 21.31
US$ 28.14
